VentriPoint Diagnostics (TSE:VPT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ventripoint Diagnostics has secured EU CE Mark certification for its advanced AI-powered heart-scanning technology, VMS+4.0, opening new market opportunities in Europe. The VMS+4.0 offers improved user experience by automating image processing and working seamlessly with magnet-free sensors, enhancing efficiency and accuracy in cardiac measurements.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
